Ocugen Inc (OCGN)

[Vector93]

I guess it depends on a couple different scenarios and my guess on the chances of them happening.

Scenario 1: (Chance of happening; 30%) FDA says they don’t have enough to move forward need more data. Stock price drops, will never go over $1 organically. In this case they would HAVE to RS to avoid de-listing and do an AS increase in order to have stock to dilute and raise funds for additional trials.

Scenario 2: (Chance of happening; 60%) FDA says they have enough to move forward, HSGX submits their BLA and about 2 months later FDA accepts it for consideration. About 6 months after that the BLA is approved. In this scenario the PPS would definitely rise above $1 so no need to RS, but HSGX would still need to raise the AS and dilute in order to fund continuing operations and prepare for market.

Scenario 3: (Chance of happening; 10%) Same as scenario 2, but before the AS increase a bigger company comes along and offers a merger, buyout, or partnership. HSGX definitely wouldn’t need to RS, and wouldn’t necessarily have to increase the AS either.